Geographic and racial variability in kidney, cardiovascular and safety outcomes with canagliflozin: A secondary analysis of the CREDENCE randomized trial.
Cardoza K, Kang A, Smyth B, Yi TW, Pollock C, Agarwal R, Bakris G, Charytan DM, de Zeeuw D, Wheeler DC, Zhang H, Cannon CP, Perkovic V, Arnott C, Levin A, Mahaffey KW.
Cardoza K, et al. Among authors: zhang h.
Diabetes Obes Metab. 2024 Jun 19. doi: 10.1111/dom.15685. Online ahead of print.
Diabetes Obes Metab. 2024.
PMID: 38895796